Schedule 13G ownership disclosure

Rhythm Pharmaceuticals Inc

Security class unavailable · CUSIP: 76243J105

Event date: 2021-02-28

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
5,570,691
Percent of class
11.1400%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-21-033076
Form type
SC 13G
Filer
PRIMECAP MANAGEMENT CO/CA/
CIK
CIK 763212
Filed
Mar 08, 2021
Reporting period
Feb 28, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub